As a direct result of the outbreak of the coronavirus disease (COVID-19) and due to circumstances beyond control, DIA has decided to postpone DIA Europe 2020 in Brussels, to June 30 – July 3, 2020.
PrimeVigilance will exhibiting and if you are attending please visit us at our booth #G5G6 to meet our team and learn about our full range of top quality and innovative life-cycle management services in pharmacovigilance, medical information, regulatory science, pharmacoepidemiology, and benefit-risk management.
PrimeVigilance is the leading provider of EU Qualified Persons responsible for Pharmacovigilance (EU-QPPVs), who fulfill specific responsibilities laid down in EU regulation and as well includes the provision of Local Contact Persons for Pharmacovigilance (LCPPV) in over 60 countries.
From its operational hubs based in Europe and the USA, PrimeVigilance manages a global Pharmacovigilance system with a choice of leading drug safety databases, stretching to more than 100 countries.
If you wish to set up a meeting with us during the event please contact us via info@Primevigilance.com or directly write to Kamel Boulami, Business Development Director who will be attending the event at email@example.com
About the DIA EUROPE meeting
DIA Europe 2020 is Europe’s largest and most forward-looking neutral healthcare conference. This annual event spans DIA’s strategic initiatives across a range of Thought Leadership streams – Clinical Development & Operations, Regulatory Science & Operations, Value and Access, Medical Affairs and many more.
To read more about the DIA EUROPE please visit the DIA Website .
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)